within Pharmacolibrary.Drugs.ATC.D;

model D07XC01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.166666666666667e-06,
    adminDuration  = 600,
    adminMass      = 6 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00161,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00429,
    k12             = 0.12,
    k21             = 0.12
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D07XC01</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Betamethasone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is used in a range of dermatological, rheumatic, and allergic conditions, as well as for fetal lung maturation in preterm labor. It is an approved and widely used medication today.</p><h4>Pharmacokinetics</h4><p>Model parameters are representative for healthy adult volunteers after intramuscular injection of betamethasone phosphate and betamethasone acetate combination, based on typical clinical dosage.</p><h4>References</h4><ol><li><p>Jobe, AH, et al., &amp; Jusko, WJ (2020). Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. <i>Clinical and translational science</i> 13(2) 391–399. DOI:<a href=\"https://doi.org/10.1111/cts.12724\">10.1111/cts.12724</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31808984/\">https://pubmed.ncbi.nlm.nih.gov/31808984</a></p></li><li><p>Moss, TJ, et al., &amp; Newnham, JP (2003). Pharmacokinetics of betamethasone after maternal or fetal intramuscular administration. <i>American journal of obstetrics and gynecology</i> 189(6) 1751–1757. DOI:<a href=\"https://doi.org/10.1016/s0002-9378(03)00825-1\">10.1016/s0002-9378(03)00825-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14710109/\">https://pubmed.ncbi.nlm.nih.gov/14710109</a></p></li><li><p>Salem, II, &amp; Najib, NM (2012). Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects. <i>Clinical therapeutics</i> 34(1) 214–220. DOI:<a href=\"https://doi.org/10.1016/j.clinthera.2011.11.022\">10.1016/j.clinthera.2011.11.022</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22154197/\">https://pubmed.ncbi.nlm.nih.gov/22154197</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D07XC01;
